Although regulation of the CaMKK/AMPK/NF-κB signaling pathway inhibits inflammation, which plays a role in modern chronic diseases such as diabetes and cancer15, the role of this pathway in articular cartilage degradation and OA progression is unknown. Here, NFKB1 is linked to diabetes mellitus.